Excoriation Disorder Medication Treatment
N-acetylcysteine (NAC) is recommended to be considered for excoriation (skin-picking) disorder across severity levels. [1] When NAC does not adequately control symptoms, additional pharmacotherapy options include selective serotonin reuptake inhibitors (SSRIs) and other glutamate-modulating agents such as memantine. [1]
Medication Selection Algorithm
- N-acetylcysteine (NAC) is selected as a glutamate-modulating agent for excoriation (skin-picking) disorder. [1]
- Selective serotonin reuptake inhibitors (SSRIs) are selected when comorbidities are present or when prior behavioral or NAC treatment has failed. [1]
- Memantine is selected as an additional glutamate-modulating option supported by emerging clinical evidence. [1]
Key Evidence Supporting N-Acetylcysteine
- A randomized clinical trial demonstrated NAC was more effective than placebo for reducing excoriation (skin-picking) symptoms. [2]
Monotherapy Versus Combination Therapy
- Behavioral therapy is a foundational treatment approach, including habit-reversal-based interventions. [1]
- Pharmacotherapy with NAC, memantine, or an SSRI can be used in conjunction with habit-reversal-based behavioral treatment. [1]
Important Clarifications
- Other pharmacologic interventions beyond NAC, SSRIs, and memantine have been described in the literature, but SSRIs and glutamate-modulating agents are the key medication classes highlighted for clinical consideration. [1]
Targets or Goals of Therapy
- The treatment goal is reduction of compulsive picking severity and improvement in functional impairment associated with excoriation (skin-picking) disorder. [2]
Common Pitfalls to Avoid
- Medication selection should not proceed without considering whether symptom severity warrants behavioral therapy or whether comorbidities or prior treatment response justify escalation beyond NAC. [1]